Background Italy has been one of the countries most affected by the SARS-CoV-2 pandemic,
and the regional healthcare system has had to quickly adapt its organization to meet the …

Mitral valve prolapse (MVP) has a prevalence of 2–3% among the population. It involves a
heterogeneous group of patients with different expressions and according to the phenotype …

Mitral regurgitation (MR) is the second most frequent indication for heart valve surgery in the
general population. 1–3

Background Little is known about the impact of transcatheter mitral valve edge‐to‐edge repair
on changes in left ventricular ejection fraction (LVEF) and the effect of an acute reduction …

OBJECTIVES The EuroSCORE II is widely used to predict 30-day mortality in patients
undergoing open and transcatheter cardiac surgery. The aim of this study is to evaluate the …

Heart failure is the worst outcome of all cardiovascular diseases and still represents
nowadays the leading cause of mortality with no effective clinical treatments, apart from organ …

OBJECTIVES The goal of this study was to assess the applicability of a novel classification
of patients with tricuspid regurgitation based on 5 stages and to evaluate outcomes following …

Aim Transcatheter aortic valve implantation (TAVI) is a mainstay in the management of
severe aortic valve stenosis in elderly patients, but there is uncertainty on their long-term …

Mitral regurgitation is the most prevalent form of moderate or severe valve disease in developed
countries. Surgery represents the standard of care for symptomatic patients with severe …

Background Although >150,000 mitral TEER procedures have been performed worldwide,
the impact of MR etiology on MV surgery after TEER remains unknown. Objectives The …